Researchers from the Weizmann Institute of Science in Rehovot, Tel Aviv-based startup Pheno.AI and chip giant NVIDIA have ...

A multistate model that enables real-time risk recalculations may help improve risk stratification for prediction of ...

People who talk in their sleep may be at greater risk of stroke, according to a study of 8,001 Chinese adults. The risk was ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.The popular research ...

Researchers collaborated on a novel, highly specific strategy to treat type 1 diabetes using a tagged beta cell transplant in ...

Q4 2024 Earnings Conference Call November 26, 2024 10:00 AM ETCompany ParticipantsMichael Lucarelli - Vice President ...

OneCare, as an accountable care organization participating in Vermont’s All-Payer Model, has been provided waivers to make it easier for the health care providers who work with OneCare to deliver high ...

Valio's Eila® powder solutions offer a premium, lactose-free base for soft ice mix manufacturers, combining advanced dairy ...

Most compounding and concentrates firms saw positive results in 2024. And in recent interviews, executives with those companies said they're hoping to keep those good vibes rolling into 2025.

Amgen's phase 2 data disappointed, but its obesity pipeline still holds potential. See why AMGN stock is appealing even without the full upside from MariTide.

In this regard, the Secretary of Health, David Kershenobich Stalnikowitz, announced the creation of a Primary Care Campaign in Metabolic Health Research, in which the entire health sector participates ...